OFIX
Orthofix Medical Inc. NASDAQ Listed Apr 24, 1992$8.95
After hrs
$8.95
+0.00%
Mkt Cap $361.8M
52w Low $8.88
0.8% of range
52w High $16.99
50d MA $11.19
200d MA $13.47
P/E (TTM)
—
EV/EBITDA
5.1x
P/B
0.8x
Debt/Equity
0.5x
ROE
-20.5%
P/FCF
-294.7x
RSI (14)
52.70
ATR (14)
$0.43
Beta
0.82
50d MA
$11.19
200d MA
$13.47
Avg Volume
467.6K
Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
3451 Plano Parkway · Lewisville, TX 75056 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | BMO | -0.29 | -0.63 | -117.2% | 12.01 | -0.2% | +3.6% | -2.0% | -1.0% | -3.5% | +0.2% | — |
| Feb 24, 2026 | BMO | -0.19 | -0.06 | +70.8% | 12.75 | +0.2% | +2.3% | +0.0% | +1.0% | +2.7% | -1.2% | — |
| Nov 4, 2025 | BMO | 0.12 | 0.20 | +66.7% | 14.87 | -0.7% | +0.7% | +0.0% | -1.9% | +1.9% | +0.5% | — |
| Aug 5, 2025 | BMO | 0.04 | 0.13 | +225.0% | 12.31 | -0.5% | +1.9% | +0.0% | +1.3% | -1.5% | +3.4% | — |
| May 6, 2025 | BMO | -0.17 | -0.08 | +52.9% | 12.06 | +0.3% | -0.3% | +0.0% | +2.4% | -1.6% | +2.6% | — |
| Feb 25, 2025 | BMO | 0.06 | 0.02 | -66.7% | 17.51 | +0.7% | -1.4% | +0.0% | -0.3% | +1.0% | -2.3% | — |
| Nov 7, 2024 | BMO | -0.14 | 0.07 | +150.0% | 18.22 | +4.1% | +6.5% | +0.0% | +3.1% | -3.8% | -3.2% | — |
| Aug 6, 2024 | BMO | -0.13 | 0.05 | +138.5% | 17.44 | +0.1% | -4.8% | +0.0% | +1.9% | -4.4% | -0.8% | — |
| May 7, 2024 | BMO | -0.32 | -0.46 | -43.8% | 13.89 | +4.9% | +7.3% | +0.0% | -2.8% | +1.0% | +3.0% | — |
| Mar 5, 2024 | BMO | -0.14 | -0.10 | +28.6% | 13.00 | +0.0% | +8.7% | +0.0% | +1.5% | -2.4% | +2.1% | — |
| Nov 8, 2023 | BMO | -0.22 | 0.07 | +131.8% | 11.86 | -9.5% | -10.4% | +0.0% | -5.9% | -3.1% | +8.0% | — |
| Aug 8, 2023 | BMO | -0.67 | 0.02 | +103.0% | 17.96 | +11.4% | +13.3% | +0.0% | -1.7% | -0.4% | -5.6% | — |
| May 9, 2023 | AMC | -0.20 | -0.10 | +50.0% | 18.46 | +0.0% | +1.8% | -2.5% | -0.8% | +3.0% | -2.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 10 | Barrington Research | Maintains | Outperform → Outperform | — | $12.42 | $12.45 | +0.2% | -0.3% | +2.2% | +0.6% | +1.2% | -3.7% |
| Mar 9 | Stifel | Maintains | Buy → Buy | — | $12.62 | $12.30 | -2.5% | -1.3% | -0.7% | -0.8% | -2.0% | -2.7% |
| Feb 26 | Canaccord Genuity | Maintains | Buy → Buy | — | $13.04 | $13.08 | +0.3% | +1.0% | +2.7% | -1.2% | -2.5% | -1.2% |
| Feb 25 | Barrington Research | Maintains | Outperform → Outperform | — | $12.75 | $12.77 | +0.2% | +2.3% | +1.0% | +2.7% | -1.2% | -2.5% |
| Feb 17 | Barrington Research | Maintains | Outperform → Outperform | — | $13.38 | $13.39 | +0.1% | +0.9% | +1.9% | +0.1% | +0.7% | -2.0% |
| Nov 5 | Barrington Research | Maintains | Outperform → Outperform | — | $14.87 | $14.77 | -0.7% | +0.7% | -1.9% | +1.9% | +0.5% | +2.3% |
| Oct 23 | Barrington Research | Maintains | Outperform → Outperform | — | $16.23 | $16.19 | -0.2% | -1.9% | +0.3% | +0.7% | -0.4% | -4.4% |
| Sep 23 | Barrington Research | Maintains | Outperform → Outperform | — | $14.86 | $14.89 | +0.2% | -0.7% | +0.3% | -2.8% | -0.6% | +0.5% |
| Jun 6 | JMP Securities | Maintains | Market Perform → Market Perform | — | $10.71 | $10.92 | +2.0% | +2.4% | +0.7% | +4.7% | -1.6% | -1.9% |
| Feb 26 | Canaccord Genuity | Maintains | Buy → Buy | — | $17.51 | $17.63 | +0.7% | -1.4% | -0.3% | +1.0% | -2.3% | +0.2% |
| Feb 26 | Roth MKM | Maintains | Buy → Buy | — | $17.51 | $17.63 | +0.7% | -1.4% | -0.3% | +1.0% | -2.3% | +0.2% |
| Nov 8 | Stifel | Upgrade | Hold → Buy | — | $18.22 | $18.97 | +4.1% | +6.5% | +3.1% | -3.8% | -3.2% | -5.6% |
| Nov 8 | Roth MKM | Maintains | Buy → Buy | — | $18.22 | $18.97 | +4.1% | +6.5% | +3.1% | -3.8% | -3.2% | -5.6% |
| May 8 | Roth MKM | Upgrade | Neutral → Buy | — | $13.89 | $14.57 | +4.9% | +7.3% | -2.8% | +1.0% | +3.0% | +0.3% |
| Mar 7 | Roth MKM | Maintains | Neutral → Neutral | — | $14.13 | $14.24 | +0.8% | +1.5% | -2.4% | +2.1% | -1.7% | +1.7% |
| Sep 12 | Stifel | Downgrade | Buy → Hold | — | $18.63 | $14.61 | -21.6% | -30.2% | +1.5% | -0.2% | -1.1% | +0.6% |
| Sep 12 | BTIG | Downgrade | Buy → Neutral | — | $18.63 | $14.61 | -21.6% | -30.2% | +1.5% | -0.2% | -1.1% | +0.6% |
| Mar 4 | Stifel | Upgrade | Hold → Buy | — | $33.63 | $34.85 | +3.6% | +6.5% | -2.7% | -2.6% | +0.0% | -2.3% |
| Nov 25 | BTIG Research | Downgrade | Buy → Neutral | — | $38.67 | $38.39 | -0.7% | -1.4% | -0.2% | -3.4% | -1.8% | +0.3% |
| Nov 25 | Stifel | Maintains | Hold → Hold | — | $38.67 | $38.39 | -0.7% | -1.4% | -0.2% | -3.4% | -1.8% | +0.3% |
| Nov 25 | Sidoti & Co. | Maintains | Buy → Buy | — | $38.67 | $38.39 | -0.7% | -1.4% | -0.2% | -3.4% | -1.8% | +0.3% |
| Nov 25 | Piper Sandler | Maintains | Neutral → Neutral | — | $38.67 | $38.39 | -0.7% | -1.4% | -0.2% | -3.4% | -1.8% | +0.3% |
| Nov 25 | Mizuho | Downgrade | Buy → Neutral | — | $38.67 | $38.39 | -0.7% | -1.4% | -0.2% | -3.4% | -1.8% | +0.3% |
| Nov 25 | Lazard | Maintains | Buy → Buy | — | $38.67 | $38.39 | -0.7% | -1.4% | -0.2% | -3.4% | -1.8% | +0.3% |
| Nov 25 | Lazard | Downgrade | Buy → Sell | — | $38.67 | $38.39 | -0.7% | -1.4% | -0.2% | -3.4% | -1.8% | +0.3% |
| Nov 25 | JMP Securities | Downgrade | Market Outperform → Perform | — | $38.67 | $38.39 | -0.7% | -1.4% | -0.2% | -3.4% | -1.8% | +0.3% |
| Nov 25 | Janney Capital | Downgrade | Buy → Neutral | — | $38.67 | $38.39 | -0.7% | -1.4% | -0.2% | -3.4% | -1.8% | +0.3% |
| Nov 25 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $38.67 | $38.39 | -0.7% | -1.4% | -0.2% | -3.4% | -1.8% | +0.3% |
| Nov 25 | Cantor Fitzgerald | Downgrade | Overweight → Neutral | — | $38.67 | $38.39 | -0.7% | -1.4% | -0.2% | -3.4% | -1.8% | +0.3% |
| Oct 20 | Stifel | Maintains | Hold → Hold | — | $34.05 | $33.78 | -0.8% | -1.1% | -0.7% | -0.6% | +0.8% | -1.3% |
| Feb 25 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $44.96 | $39.75 | -11.6% | -18.4% | -0.6% | -1.6% | -1.6% | +3.1% |
| Feb 25 | Sidoti & Co. | Maintains | Buy → Buy | — | $44.96 | $39.75 | -11.6% | -18.4% | -0.6% | -1.6% | -1.6% | +3.1% |
| Oct 29 | Cantor Fitzgerald | Downgrade | Overweight → Neutral | — | $49.02 | $41.01 | -16.3% | -15.1% | +1.3% | -0.3% | -1.2% | +3.1% |
| Feb 26 | BTIG | Downgrade | Buy → Neutral | — | $67.71 | $57.90 | -14.5% | -11.5% | -0.6% | +2.6% | -3.5% | -2.6% |
| Feb 26 | BTIG Research | Downgrade | Buy → Neutral | — | $67.71 | $57.90 | -14.5% | -11.5% | -0.6% | +2.6% | -3.5% | -2.6% |
| Jun 1 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $54.65 | $55.40 | +1.4% | +1.4% | +0.7% | -0.2% | +1.3% | -1.9% |
| Jun 21 | BTIG Research | Maintains | Buy → Buy | — | $45.12 | $45.45 | +0.7% | +1.7% | -0.4% | +1.9% | -0.6% | -1.9% |
| Jun 14 | Ladenburg Thalmann | Maintains | Buy → Buy | — | $44.90 | $45.15 | +0.6% | +0.4% | -0.7% | +0.2% | +0.8% | -0.1% |
| May 23 | SunTrust Robinson Humphrey | Maintains | Buy → Buy | — | $41.73 | $42.02 | +0.7% | +2.0% | -0.4% | +0.3% | +0.0% | -0.5% |
| May 9 | Janney Capital | Downgrade | Buy → Neutral | — | $32.00 | $26.35 | -17.7% | -15.6% | -2.1% | -0.9% | +0.2% | -0.2% |
| May 9 | Janney Montgomery Scott | Downgrade | Buy → Neutral | — | $32.00 | $26.35 | -17.7% | -15.6% | -2.1% | -0.9% | +0.2% | -0.2% |
| May 9 | JMP Securities | Downgrade | Market Outperform → Market Perform | — | $32.00 | $26.35 | -17.7% | -15.6% | -2.1% | -0.9% | +0.2% | -0.2% |
| May 9 | Mizuho | Downgrade | Buy → Neutral | — | $32.00 | $26.35 | -17.7% | -15.6% | -2.1% | -0.9% | +0.2% | -0.2% |
| May 9 | JMP Securities | Downgrade | Market Outperform → Perform | — | $32.00 | $26.35 | -17.7% | -15.6% | -2.1% | -0.9% | +0.2% | -0.2% |
| May 9 | Lazard | Downgrade | Buy → Sell | — | $32.00 | $26.35 | -17.7% | -15.6% | -2.1% | -0.9% | +0.2% | -0.2% |
| Feb 25 | Piper Sandler | Maintains | Neutral → Neutral | — | $36.95 | $37.05 | +0.3% | -1.2% | -1.5% | +0.7% | +2.9% | +0.9% |
| Jan 3 | Lazard | Maintains | Buy → Buy | — | $39.94 | $39.84 | -0.3% | -4.9% | +0.0% | -0.3% | -4.4% | +2.0% |
| Oct 31 | Piper Sandler | Maintains | Neutral → Neutral | — | $39.31 | $39.23 | -0.2% | +0.9% | +0.6% | -0.6% | +0.7% | -0.4% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | Engine Capital Management, LP10% | — | Buy | 904 | $12.15 | $11K | 382,450 | -3.48% | +0.66% |
| May 7, 2026 | Engine Capital Management, LP10% | — | Buy | 1,808 | $12.20 | $22K | 381,546 | -3.48% | +0.66% |
| May 7, 2026 | Engine Capital Management, LP10% | — | Buy | 9,096 | $12.15 | $110K | 3,848,573 | -3.48% | +0.66% |
| May 7, 2026 | Engine Capital Management, LP10% | — | Buy | 18,192 | $12.20 | $222K | 3,839,477 | -3.48% | +0.66% |
| May 6, 2026 | Engine Capital Management, LP10% | — | Buy | 3,792 | $12.23 | $46K | 379,738 | -3.48% | +0.66% |
| May 6, 2026 | Engine Capital Management, LP10% | — | Buy | 38,154 | $12.23 | $467K | 3,821,285 | -3.48% | +0.66% |
| May 5, 2026 | Engine Capital Management, LP10% | — | Buy | 2,911 | $11.99 | $35K | 375,946 | -3.48% | +0.66% |
| May 5, 2026 | Engine Capital Management, LP10% | — | Buy | 110,039 | $11.99 | $1.3M | 3,783,131 | -3.48% | +0.66% |
8-K · 5.02
!!! Very High
Orthofix Medical Inc. -- 8-K 5.02: Executive Change
Jun 11
8-K · 7.01
! Medium
Orthofix Medical Inc. -- 8-K 7.01: Regulation FD Disclosure
May 21
8-K · 2.02
!! High
Orthofix Medical Inc. -- 8-K 2.02: Earnings Results
Orthofix Medical reported Q1 2026 earnings results, providing investors updated financial performance data to assess the orthopedic medical device company's operational trajectory and profitability.
May 5
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
OrthFix's executive departure under existing contractual terms suggests planned leadership transition rather than crisis, which investors should monitor for strategic direction clarity and management continuity impact.
Apr 9
8-K
Orthofix Medical Inc. -- 8-K Filing
Orthofix Medical uses non-GAAP metrics like free cash flow and adjusted net sales to provide investors with performance measures that exclude foreign currency fluctuations and capital expenditures.
Feb 24
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 1,655,449 | $19M | New | Mar 2026 |
| 2 | Millennium Management | 1,066,900 | $12M | Reduced | Mar 2026 |
| 3 | Morgan Stanley | 449,286 | $7M | Added | Dec 2025 |
| 4 | Acadian Asset Management Llc | 559,837 | $6M | Added | Mar 2026 |
| 5 | Vanguard Portfolio Management Llc | 396,568 | $5M | New | Mar 2026 |
| 6 | Northern Trust Corp | 337,338 | $4M | Added | Mar 2026 |
| 7 | Tudor Investment Corp | 262,974 | $3M | New | Mar 2026 |
| 8 | Bank Of America Corp /de/ | 212,169 | $2M | Reduced | Mar 2026 |
| 9 | Russell Investments Group, Ltd. | 211,734 | $2M | Added | Mar 2026 |
| 10 | Arrowstreet Capital, Limited Partnership | 200,230 | $2M | Reduced | Mar 2026 |
| 11 | Aqr Capital Management Llc | 189,124 | $2M | Added | Mar 2026 |
| 12 | Jpmorgan Chase & Co | 190,367 | $2M | Reduced | Mar 2026 |
| 13 | Nuveen, Llc | 173,734 | $2M | Reduced | Mar 2026 |
| 14 | Point72 Asset Management | 158,880 | $2M | Added | Mar 2026 |
| 15 | Voya Investment Management Llc | 117,299 | $2M | Reduced | Dec 2025 |
| 16 | Great Lakes Advisors, Llc | 153,866 | $2M | Reduced | Mar 2026 |
| 17 | Jane Street Group, Llc | 111,622 | $2M | Reduced | Dec 2025 |
| 18 | Citadel Advisors Llc | 126,403 | $1M | Added | Mar 2026 |
| 19 | Ubs Group Ag | 117,838 | $1M | Added | Mar 2026 |
| 20 | Bank Of New York Mellon Corp | 113,605 | $1M | — | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$361.8M
Enterprise Value
$477.7M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.21x
P/B
0.79x
P/S
0.43x
P/FCF
-294.68x
EV/EBITDA
5.05x
Shares Out
39.9M
Financials (TTM)
Revenue
$825.4M
Net Income
-$60.0M
EBITDA
$94.5M
Free Cash Flow
-$1.3M
Op Cash Flow
$33.3M
EPS Basic
$-2.28
EPS Diluted
$-1.51
EPS Forward
$-1.31
Gross Margin
69.0%
Op Margin
-4.0%
Net Margin
-7.3%
Balance Sheet
Total Assets
$850.6M
Total Liab.
$400.6M
Total Equity
$450.0M
Cash
$82.0M
LT Debt
$182.8M
Book Value/Sh
$11.28
Debt/Equity
0.51x
Current Ratio
2.45
Quick Ratio
2.24
Returns & Growth
ROE
-20.5%
ROA
-10.8%
ROIC
-10.0%
Rev Growth YoY
+2.9%
EPS Growth YoY
+30.9%
Price Returns
2W
-24.6%
1M
-21.2%
3M
-31.5%
6M
-42.4%
12M
-17.6%
Technicals
52W High
$16.99
52W Low
$8.88
50d MA
$11.19
200d MA
$13.47
RSI (14)
52.70
ATR (14)
$0.43
Beta
0.82
Avg Volume
468K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$18.00
High
$18.00
Low
$18.00
Median
$18.00
Data updated apr 26, 2026 5:00pm
· Source: financialmodelingprep.com